PSIL Fees and Costs — AdvisorShares Psychedelics ETF

Data updated: 2026-09-10

The net expense ratio is 1.00%: a 0.60% management fee plus 1.23% other expenses, less a 0.84% fee waiver. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $149K in broker commissions, 0.6898% of average net assets, and portfolio turnover was 107%.

PSIL Fees and Expenses

Annual operating expenses and sales charges of PSIL. Prospectus, as of November 1, 2025.

Annual operating expenses
Management fee0.60%
12b-1 fee0.00%
Other expenses1.23%
Gross expense ratio1.84%
Fee waiver−0.84%
Net expense ratio1.00%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

PSIL Costs Over Time

On $10,000 invested in PSIL, assuming 5% a year before costs, total costs come to $1,042 over 5 years, cutting the return by 1.77% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.00%)$105$325$560
Trading costs (broker commissions)$72$224$386
Lost growth on money paid in costs$0$27$96
Total costs$177$577$1,042
Value after costs$10,323$10,999$11,720
Impact on return, per year1.77%1.77%1.77%

PSIL Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending June 30, 2026.

  • Explicit cost rate (commissions ÷ average net assets): 0.6898%
  • Total broker commissions: $149K
  • Bought from dealers (principal trades, not a cost): $22.7M
  • Portfolio turnover (prospectus): 107%
  • Securities on loan, average value: $3.0M
  • Net income from securities lending: $61K (0.281% of average net assets)

PSIL Agency Brokers

Commissions paid.

BrokerAmountShare
VIRTU AMERICAS LLC$149K100.00%

PSIL Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
VIRTU AMERICAS LLC$14.1M62.05%
Jane Street Execution Services, LLC$4.4M19.61%
Mirae Asset Securities (USA) Inc.$3.4M14.97%
SAGE THERAPEUTICS, INC.$763K3.37%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.